1. Home
  2. HAFN vs ICUI Comparison

HAFN vs ICUI Comparison

Compare HAFN & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hafnia Limited

HAFN

Hafnia Limited

HOLD

Current Price

$5.75

Market Cap

2.9B

Sector

N/A

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$153.17

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAFN
ICUI
Founded
2012
1984
Country
Singapore
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.6B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
HAFN
ICUI
Price
$5.75
$153.17
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$179.50
AVG Volume (30 Days)
1.1M
212.9K
Earning Date
02-26-2026
02-26-2026
Dividend Yield
6.95%
N/A
EPS Growth
N/A
N/A
EPS
0.61
N/A
Revenue
$2,221,808,000.00
$2,320,363,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.30
N/A
P/E Ratio
$9.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.61
$107.00
52 Week High
$6.64
$175.51

Technical Indicators

Market Signals
Indicator
HAFN
ICUI
Relative Strength Index (RSI) 52.10 55.10
Support Level $5.63 $152.38
Resistance Level $5.97 $160.29
Average True Range (ATR) 0.13 5.38
MACD 0.03 0.32
Stochastic Oscillator 61.31 67.83

Price Performance

Historical Comparison
HAFN
ICUI

About HAFN Hafnia Limited

Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: